Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fragmin for prevention of catheter-related complications in cancer patients
NCT00006083Phase 3Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Apr 2000
- Primary completion
- Nov 2000
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dalteparin in catheter-related thrombosis (CRT), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Apr 2000; status: completed.
02
Drugs
dalteparin
03
Conditions
catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on NCT00006083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006083.